MedKoo Cat#: 599101 | Name: Quisultazine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Quisultazine is an inhibitor of nocturnal gastric secretion.

Chemical Structure

Quisultazine
Quisultazine
CAS#64099-44-1

Theoretical Analysis

MedKoo Cat#: 599101

Name: Quisultazine

CAS#: 64099-44-1

Chemical Formula: C21H25N3O2S2

Exact Mass: 415.1388

Molecular Weight: 415.57

Elemental Analysis: C, 60.70; H, 6.06; N, 10.11; O, 7.70; S, 15.43

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Quisultazine; Quisultidina; Quisultidinum;
IUPAC/Chemical Name
N,N-dimethyl-10-(quinuclidin-3-yl)-10H-phenothiazine-2-sulfonamide
InChi Key
HTHHBTMNLHMBHQ-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H25N3O2S2/c1-22(2)28(25,26)16-7-8-21-18(13-16)24(17-5-3-4-6-20(17)27-21)19-14-23-11-9-15(19)10-12-23/h3-8,13,15,19H,9-12,14H2,1-2H3
SMILES Code
O=S(C(C=C1N2C3CN4CCC3CC4)=CC=C1SC5=C2C=CC=C5)(N(C)C)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 415.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Wilson JA, Boyd EJ, Wormsley KG. Effects of some polycyclic drugs on gastric secretion and on the healing of duodenal ulcers. Acta Psychiatr Scand Suppl. 1985;320:93-7. PubMed PMID: 2864795. 2: Vatier J, Bessac JF, Bonfils S. The gastric antisecretory activity of a phenothiazine molecule, LM 24056. Arzneimittelforschung. 1982;32(8):815-9. PubMed PMID: 6814453. 3: Kauffmann JM, Patriarche GJ, Viré JC, Heineman WR. Unusual electrochemical behaviour of a new phenothiazine. Analyst. 1985 Apr;110(4):349-51. PubMed PMID: 4025830. 4: Boyd EJ, Wormsley KG. Inhibition of pentagastrin-stimulated and overnight gastric secretion by LM24056, a new phenothiazine-derived antisecretory drug. Lancet. 1981 Feb 28;1(8218):471-3. PubMed PMID: 6110093. 5: Mizoule J, Rataud J, Le Fur G, Jozefczak C, Quarteronet D, Uzan A. On the long acting gastric antisecretory activity of LM 24056 a non H2 antagonist. Life Sci. 1982 Oct 4;31(14):1473-85. PubMed PMID: 7144436. 6: Vatier J, Poitevin C, Vitre MT, Riquet W, Martin P, Bonfils S. The antigastrinic effect of a phenothiazine (LM 24056) prevents gastric secretory activity of histamine. Agents Actions. 1986 Nov;19(3-4):174-9. PubMed PMID: 3103399. 7: Vatier J, Bessac JF, Bonfils S. N,N-dimethyl-10-(3-quinuclidinyl)-2-phenothiazine sulfonamide (LM 24056): mode of action of its gastric antisecretory effect. Arzneimittelforschung. 1983;33(11):1573-6. PubMed PMID: 6140926.